Related Experiment Video
Updated: Apr 26, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Prenatal SSRI exposure: Effects on later child development
Tone Kristine Hermansen1, Annika Melinder
1a The Cognitive Developmental Research Unit, Department of Psychology , University of Oslo , Oslo , Norway.
Insights
Prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) may not impact early child development but could lead to later cognitive difficulties. More research is needed to clarify the long-term effects of SSRI exposure during pregnancy.
Area of Science:
- Neuroscience
- Developmental Psychology
- Pharmacology
Background:
- Selective serotonin reuptake inhibitors (SSRIs) cross the placenta, potentially affecting fetal neurodevelopment.
- Maternal depression during pregnancy poses risks to fetal and child outcomes.
- Guidelines often suggest discontinuing SSRIs during pregnancy, but untreated depression also has risks.
Purpose of the Study:
- To review and integrate research on SSRI pharmacological mechanisms.
- To examine the effects of prenatal SSRI exposure on fetal brain development.
- To assess the impact on child cognitive function following prenatal SSRI exposure.
Main Methods:
- Literature review and synthesis of existing studies.
- Analysis of research differentiating early versus late developmental outcomes.
- Evaluation of studies on cognitive function and behavioral problems.
Main Results:
- Early cognitive development studies show no negative effects from prenatal SSRI exposure.
- Studies on later development suggest potential cognitive difficulties and behavioral issues.
- Findings across studies are not fully consistent, indicating uncertainty.
Conclusions:
- Prenatal SSRI exposure may have latent effects on cognitive development.
- The extent and certainty of these effects remain unclear.
- Further research is required to understand the long-term impact on child development.
Abstract:
The aim of this review is to integrate research on the pharmacological mechanisms of selective serotonin reuptake inhibitors (SSRIs) and the following effects on fetal brain development and child cognitive function seen in children with prenatal exposure to SSRIs. As antidepressants are transferred from the mother to the fetus through the placenta, the fetus is vulnerable to alterations in neurotransmission and possibly altered neural functioning. Because of this risk, pregnant women suffering from depression are often advised to discontinue their use of antidepressants during pregnancy. Though, maternal untreated depression may also have negative consequences for the fetus and child after birth. In the present review, we find a distinction between studies of early versus late development. Studies on early cognitive development indicate no negative effects, while studies on later development report some cognitive difficulties and behavioral problems, indicating latent effects of exposure. However, the reviewed studies are not all converging, and it is not clear whether and to what extent prenatal SSRI exposure affects cognitive development.
More Related Videos
11:01Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
Published on: December 14, 2014
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
Related Concept Videos
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Socioemotional Development during Infancy
Primary Temperament Types
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Teratogenicity
Development of the Oral Microbiota
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.